Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 24505127)

1.

Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors.

Panosyan EH, Wang Y, Xia P, Lee WN, Pak Y, Laks DR, Lin HJ, Moore TB, Cloughesy TF, Kornblum HI, Lasky JL 3rd.

Mol Cancer Res. 2014 May;12(5):694-702. doi: 10.1158/1541-7786.MCR-13-0576. Epub 2014 Feb 6.

3.

Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines.

Su N, Pan YX, Zhou M, Harvey RC, Hunger SP, Kilberg MS.

Pediatr Blood Cancer. 2008 Feb;50(2):274-9.

PMID:
17514734
5.

Pharmacologic blockade of FAK autophosphorylation decreases human glioblastoma tumor growth and synergizes with temozolomide.

Golubovskaya VM, Huang G, Ho B, Yemma M, Morrison CD, Lee J, Eliceiri BP, Cance WG.

Mol Cancer Ther. 2013 Feb;12(2):162-72. doi: 10.1158/1535-7163.MCT-12-0701. Epub 2012 Dec 12.

6.

Pancreatic tumor sensitivity to plasma L-asparagine starvation.

Dufour E, Gay F, Aguera K, Scoazec JY, Horand F, Lorenzi PL, Godfrin Y.

Pancreas. 2012 Aug;41(6):940-8. doi: 10.1097/MPA.0b013e318247d903.

PMID:
22513289
7.

Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice.

Kokkinakis DM, Hoffman RM, Frenkel EP, Wick JB, Han Q, Xu M, Tan Y, Schold SC.

Cancer Res. 2001 May 15;61(10):4017-23.

8.

Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941).

Jarrar M, Gaynon PS, Periclou AP, Fu C, Harris RE, Stram D, Altman A, Bostrom B, Breneman J, Steele D, Trigg M, Zipf T, Avramis VI.

Pediatr Blood Cancer. 2006 Aug;47(2):141-6.

PMID:
16425271
9.

A combined preclinical therapy of cannabinoids and temozolomide against glioma.

Torres S, Lorente M, Rodríguez-Fornés F, Hernández-Tiedra S, Salazar M, García-Taboada E, Barcia J, Guzmán M, Velasco G.

Mol Cancer Ther. 2011 Jan;10(1):90-103. doi: 10.1158/1535-7163.MCT-10-0688.

10.

The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.

Pyrko P, Schönthal AH, Hofman FM, Chen TC, Lee AS.

Cancer Res. 2007 Oct 15;67(20):9809-16.

11.

[Relationship between asparagine synthetase expression level and cell sensitivity to L-asparaginase in human leukemic cell lines].

Li BS, He YY, Luo CY, Jiang H, Shen SH, Jiang LM, Zhang B, Gu LJ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Jun;18(3):559-63. Chinese.

PMID:
20561401
12.

The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.

Majlessipour F, Avramis IA, Kwock R, Weinberg KI, Avrami VI.

Anticancer Res. 2002 May-Jun;22(3):1361-8.

PMID:
12168812
13.
14.

Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961).

Panosyan EH, Grigoryan RS, Avramis IA, Seibel NL, Gaynon PS, Siegel SE, Fingert HJ, Avramis VI.

Anticancer Res. 2004 Mar-Apr;24(2C):1121-5.

15.

Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma.

Zhang B, Dong LW, Tan YX, Zhang J, Pan YF, Yang C, Li MH, Ding ZW, Liu LJ, Jiang TY, Yang JH, Wang HY.

Br J Cancer. 2013 Jul 9;109(1):14-23. doi: 10.1038/bjc.2013.293. Epub 2013 Jun 13.

16.

Toca 511 gene transfer and 5-fluorocytosine in combination with temozolomide demonstrates synergistic therapeutic efficacy in a temozolomide-sensitive glioblastoma model.

Huang TT, Hlavaty J, Ostertag D, Espinoza FL, Martin B, Petznek H, Rodriguez-Aguirre M, Ibañez CE, Kasahara N, Gunzburg W, Gruber HE, Pertschuk D, Jolly DJ, Robbins JM.

Cancer Gene Ther. 2013 Oct;20(10):544-51. doi: 10.1038/cgt.2013.51. Epub 2013 Aug 23.

PMID:
23969884
17.

Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.

Ramachandran C, Nair SM, Escalon E, Melnick SJ.

J Complement Integr Med. 2012 Aug 10;9:Article 20. doi: 10.1515/1553-3840.1614.

PMID:
22944718
19.

Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence.

Gilbert CA, Daou MC, Moser RP, Ross AH.

Cancer Res. 2010 Sep 1;70(17):6870-9. doi: 10.1158/0008-5472.CAN-10-1378. Epub 2010 Aug 24.

20.

p53 Small-molecule inhibitor enhances temozolomide cytotoxic activity against intracranial glioblastoma xenografts.

Dinca EB, Lu KV, Sarkaria JN, Pieper RO, Prados MD, Haas-Kogan DA, Vandenberg SR, Berger MS, James CD.

Cancer Res. 2008 Dec 15;68(24):10034-9. doi: 10.1158/0008-5472.CAN-08-1687.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk